Summit Therapeutics' ivonescimab outperforms Keytruda in Phase 3 lung cancer trials. Crucial Western market approval depends ...

This is our global initial public offering guide. It will help you navigate the US portion of a global IPO – in other words, an IPO in which you ...

Redwire's valuation and growth prospects look attractive, but a closer look at the business model suggests some caution. Read ...

At this time, I would like to welcome everyone to the SeaStar Medical year-end 2024 financial results conference call. (Operator Instructions) Thank you. I would now like to turn the call over to ...

After hours: March 26 at 7:55:48 PM EDT Loading Chart for CBOE ...

We are streamlining some climate pages including removal of the Model Summary. From 10 December our climate information is available on the Southern Hemisphere monitoring and Southern Hemisphere ...